From understanding how government intervention affects markets to new approaches for digital leadership and more, Johns Hopkins Carey Business School faculty are dedicated to understanding the business implications of the coronavirus (COVID-19). And by working closely with health experts across the university and hospital who are leading the medical response to COVID-19, Carey’s faculty experts bring a nuanced understanding of the virus’ economic impact.
Johns Hopkins remains committed to translating high quality research into actionable information for our Baltimore neighbors and communities around the world. Support our work with a gift to the COVID-19 Fund.
“Our results suggest that sharing information about the vaccination behavior with a person’s social networks may be more effective at reducing the person’s vaccine hesitancy than nationwide or regional vaccination statistics.”
Haiyang Yang, PhD
In the media
Our faculty experts are on the cutting of research initiatives to advance the business of health.
- Ge Bai The Health 202: Pandemic relief funds boosted surpluses for some large hospitals Washington Post
- Tinglong Dai How Hard Could It Be to Vaccinate the Whole World? This Hard. New York Times
- Ge Bai Hospitals Serving the Poor Struggled During COVID. Wealthy Hospitals Made Millions NPR
- Kathleen Day Are we headed for a Roaring ’20s economy? Marketplace
- Manuel Hermosilla How Pfizer Became the Status Vax Slate
- Tinglong Dai COVID exposed global supply chain flaws. Can Biden bring manufacturing back to the U.S.? Fortune
- Alex Triantis Covid boosts appeal of Carey’s healthcare specialism Financial Times
- Brian Gunia This School’s Name Is Synonymous with the Covid Fight. Here’s What It Did to Get MBAs Back in Class Poets & Quants
Carey alumnus Stephane Labossiere is delivering critical services to underserved, at-risk groups
A Q&A with Bill Enright, CEO of Vaccitech